https://milanapharm.com/milanapharm-receives-notice-of-allowance-from-u-s-patent-office-for-lidocaine-topical-formulation/2021-05-01T21:32:26+00:00https://milanapharm.com/milanapharm-announces-publication-of-wound-pain-study/2021-06-11T17:58:17+00:00https://milanapharm.com/dare-bioscience-inc-announces-licensing-and-global-rights-to-novel-phase-iii-product-candidate-for-the-treatment-of-bacterial-vaginosis/2021-05-01T21:54:50+00:00